Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid KK Matthay, JG Villablanca, RC Seeger, DO Stram, RE Harris, ... New England Journal of Medicine 341 (16), 1165-1173, 1999 | 2235 | 1999 |
Determination of subcutaneous tumor size in athymic (nude) mice MM Tomayko, CP Reynolds Cancer chemotherapy and pharmacology 24, 148-154, 1989 | 1970 | 1989 |
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma AL Yu, AL Gilman, MF Ozkaynak, WB London, SG Kreissman, HX Chen, ... New England Journal of Medicine 363 (14), 1324-1334, 2010 | 1891 | 2010 |
Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy MH Kang, CP Reynolds Clinical cancer research 15 (4), 1126-1132, 2009 | 1311 | 2009 |
Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group … KK Matthay, CP Reynolds, RC Seeger, H Shimada, ES Adkins, ... Journal of clinical oncology 27 (7), 1007, 2009 | 980 | 2009 |
Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma CJ Thiele, CP Reynolds, MA Israel Nature 313 (6001), 404-406, 1985 | 780 | 1985 |
Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children’s Oncology Group WB London, RP Castleberry, KK Matthay, AT Look, RC Seeger, ... J Clin Oncol 23 (27), 6459-65, 2005 | 681 | 2005 |
Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma M Sausen, RJ Leary, S Jones, J Wu, CP Reynolds, X Liu, A Blackford, ... Nature genetics 45 (1), 12-17, 2013 | 509 | 2013 |
The pediatric preclinical testing program: description of models and early testing results PJ Houghton, CL Morton, C Tucker, D Payne, E Favours, C Cole, ... Pediatric blood & cancer 49 (7), 928-940, 2007 | 499 | 2007 |
Ceramide synthesis and metabolism as a target for cancer therapy CP Reynolds, BJ Maurer, RN Kolesnick Cancer letters 206 (2), 169-180, 2004 | 450 | 2004 |
Retinoid therapy of high-risk neuroblastoma CP Reynolds, KK Matthay, JG Villablanca, BJ Maurer Cancer letters 197 (1-2), 185-192, 2003 | 393 | 2003 |
Outcome after reduced chemotherapy for intermediate-risk neuroblastoma DL Baker, ML Schmidt, SL Cohn, JM Maris, WB London, A Buxton, ... New England Journal of Medicine 363 (14), 1313-1323, 2010 | 343 | 2010 |
The majority of total nuclear-encoded non-ribosomal RNA in a human cell is' dark matter'un-annotated RNA P Kapranov, G St Laurent, T Raz, F Ozsolak, CP Reynolds, ... BMC biology 8, 1-15, 2010 | 329 | 2010 |
Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)-retinamide in neuroblastoma cell lines BJ Maurer, LS Metelitsa, RC Seeger, MC Cabot, CP Reynolds Journal of the National Cancer Institute 91 (13), 1138-1146, 1999 | 327 | 1999 |
Antitumor activity of hu14. 18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study S Shusterman, WB London, SD Gillies, JA Hank, SD Voss, RC Seeger, ... Journal of Clinical Oncology 28 (33), 4969, 2010 | 318 | 2010 |
Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines N Keshelava, JJ Zuo, P Chen, SN Waidyaratne, MC Luna, CJ Gomer, ... Cancer research 61 (16), 6185-6193, 2001 | 292 | 2001 |
Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial SG Kreissman, RC Seeger, KK Matthay, WB London, R Sposto, SA Grupp, ... The lancet oncology 14 (10), 999-1008, 2013 | 289 | 2013 |
High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. N Hailat, DR Keim, RF Melhem, XX Zhu, C Eckerskorn, GM Brodeur, ... The Journal of clinical investigation 88 (1), 341-345, 1991 | 287 | 1991 |
Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma TJ Moss, CP Reynolds, HN Sather, SG Romansky, GD Hammond, ... New England Journal of Medicine 324 (4), 219-226, 1991 | 282 | 1991 |
Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641 DR Strother, WB London, ML Schmidt, GM Brodeur, H Shimada, ... Journal of clinical oncology 30 (15), 1842, 2012 | 267 | 2012 |